10 year portfolio - New Portfolio
Patel54
10 year portfolioIndividual Investor
Ranked #76,416 out of 858,971 TipRanks' Investors
Success Rate
59 out of 85
profitable transactions
profitable transactions
Average Return
35.89%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▼ 1.34%
6-Month Return▲ 13.57%
12-Month Return▲ 68.03%
YTD Return▼ 3.77%
Total Return▲ 154.69%
Best Trade
Bio
Viewer discretion is advised!
Performance
20.94%0-20.94%
▲ 12.88%
▲ 3.56%
▲ 3.75%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 20.94%
Oct 2025
▼ 3.68%
▲ 0.19%
▼ 2.89%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 8.32%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 4.68%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 2.34%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 9.23%
Mar 2026
▲ 7.53%
▲ 5.50%
▲ 3.70%
Apr 2026
▲ 12.88%▲ 3.56%▲ 3.75%
▲ 10.96%▲ 2.38%▲ 20.94%
▼ 3.68%▲ 0.19%▼ 2.89%
▼ 0.10%▲ 0.08%▲ 8.32%
▲ 4.06%▲ 1.47%▲ 4.68%
▼ 1.12%▼ 0.86%▼ 2.34%
▲ 0.60%▼ 4.94%▼ 9.23%
▲ 7.53%▲ 5.50%▲ 3.70%
Recent Activity
RTX
―
▲ 153.15%
2
Close
Apr 09, 2026
BridgeBio Pharma
16.34%
▲ 230.52%
2
Sell
Apr 09, 2026
TransMedics Group
―
▲ 78.96%
3
Close
Apr 09, 2026
Viridian Therapeutics
―
▲ 8.62%
2
Close
Apr 09, 2026
Trade Desk
―
▼ 62.11%
2
Close
Apr 09, 2026
IDEAYA Biosciences
8.61%
▲ 5.87%
1
Open
Apr 09, 2026
Kura Oncology
6.86%
▼ 1.47%
1
Open
Apr 09, 2026
Crinetics Pharmaceuticals
10.14%
▼ 2.45%
1
Open
Apr 09, 2026
ServiceNow
7.01%
▼ 0.84%
1
Open
Apr 09, 2026
TG Therapeutics
―
▲ 101.41%
2
Close
May 29, 2025
AstraZeneca
―
▲ 19.08%
2
Close
Mar 18, 2025
Genmab
―
▲ 13.29%
2
Close
Feb 28, 2025
Advanced Micro Devices
―
▼ 17.22%
2
Close
Feb 28, 2025
Canadian Natural
―
▲ 7.09%
3
Close
Jan 20, 2025
Schlumberger
―
▲ 10.19%
2
Close
Jan 17, 2025
Neurocrine
―
▲ 14.02%
2
Close
Jan 17, 2025
Apellis Pharmaceuticals
―
▲ 17.56%
3
Close
Jan 07, 2025
Pfizer
―
▲ 5.95%
2
Close
Dec 27, 2024
Immunovant
6.59%
▲ 0.14%
10
Buy
Dec 27, 2024
RegenXBio
―
▼ 13.69%
3
Close
Nov 25, 2024